不匹配现象:多中心艾滋病队列研究/妇女机构间HIV研究联合队列中干血斑替诺福韦二磷酸浓度低但病毒载量抑制
本研究评估了接受替诺福韦艾拉酚胺(TAF)为基础抗逆转录病毒治疗的HIV感染者中,干血斑替诺福韦二磷酸(TFV-DP)浓度低但病毒载量抑制(不匹配)的发生率及相关因素。结果显示女性不匹配率为39%,男性为27%;较高的eGFR、体重、较低的自报依从性以及男性中的黑人种族与不匹配几率升高相关。
要点
- 在TAF治疗者中,病毒载量抑制但TFV-DP低的不匹配现象常见,女性39%,男性27%。
- 较高eGFR、体重增加、依从性低于95%与不匹配几率升高相关。
- 男性中黑人种族与不匹配几率显著升高相关。
核心结论
- 在接受TAF为基础方案的HIV感染者中,病毒载量抑制但TFV-DP浓度低的不匹配现象在女性中占39%,男性中占27%。
- 体重、eGFR、自报依从性以及男性中的黑人种族与不匹配几率升高相关。
研究设计与样本
- 研究基于多中心艾滋病队列研究/妇女机构间HIV研究联合队列,纳入接受TAF为基础抗逆转录病毒治疗至少3个月的参与者,共测量627人(63%女性)的干血斑样本。
- 采用逻辑回归评估预设协变量与药物学病毒学不匹配(血浆病毒载量<200拷贝/mL且细胞内TFV-DP浓度<1800 fmol/punches)的关联。
主要发现
- 病毒载量<200拷贝/mL和≥200拷贝/mL者的TFV-DP中位数(IQR)分别为2375(1493-3340)和264(13-949)fmol/punches。
- 女性中,较高的eGFR(每增加15 mL/min/1.73 m2)、体重(每增加15 kg)和较低的自报依从性(<95%)与不匹配几率升高相关,OR分别为1.77(1.40-2.28)、1.32(1.11-1.57)和5.12(2.16-12.90)。
- 男性中,较高的eGFR、体重、黑人种族和较低依从性与不匹配几率升高相关,OR分别为1.75(1.22-2.62)、1.66(1.19-2.39)、7.53(2.87-22.28)和9.61(2.17-51.95)。
关键数值与推荐
- 不匹配定义为血浆病毒载量<200拷贝/mL且细胞内TFV-DP浓度<1800 fmol/punches。
- 女性不匹配率为39%,男性为27%。
临床怎么用
- 对于接受TAF为基础方案的HIV感染者,应考虑体重、eGFR、依从性和男性中的黑人种族等因素对不匹配风险的影响。
- 这些特征可用于设计依从性干预措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tenofovir-diphosphate (TFV-DP) in dried blood spots (DBS) is an objective drug concentration measure predictive of future viremia in virally suppressed persons with human immunodeficiency virus (PWH) on TFV-based antiretroviral therapy (ART). Viral load (VL):TFV-DP mismatch (suppressed VL despite low TFV-DP concentrations) may increase future viremia risk. Previously, Black race, male sex, and higher body mass index were associated with lower TFV-DP concentrations among PWH receiving tenofovir disoproxil fumarate. This study assessed mismatch rates in PWH on tenofovir alafenamide (TAF). METHODS: DBS samples were obtained from Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort participants receiving TAF-based ART for ≥3 months. Associations between prespecified covariates and pharmacologic virologic mismatch (plasma VL <200 copies/mL and intracellular TFV-DP concentrations <1800 fmol/punches) were evaluated using logistic regression. RESULTS: DBS were measured in 627 PWH (63% female) with a median (IQR) age of 55 (47-61) years. TFV-DP for VLs <200 copies/mL and ≥200 copies/mL was 2375 (1493-3340) and 264 (13-949) fmol/punches, respectively. Females experienced 39% mismatch. Higher estimated glomerular filtration rate (eGFR; +15 mL/min/1.73 m2), weight (+15 kg), and lower self-reported adherence (<95%) were associated with higher mismatch odds: 1.77 (1.40-2.28), 1.32 (1.11-1.57), and 5.12 (2.16-12.90), respectively. Males experienced 27% mismatch. Higher eGFR, weight, Black race, and lower adherence were associated with higher mismatch odds: 1.75 (1.22-2.62), 1.66 (1.19-2.39), 7.53 (2.87-22.28), and 9.61 (2.17-51.95), respectively. CONCLUSIONS: Weight, eGFR, self-reported adherence, and Black race in males were associated with mismatch. These characteristics should be considered when designing adherence interventions.
引用
- Mann SC, Lykins D, Coyle RP, et al. In the Mismatch: Viral Suppression Despite Low Tenofovir-Diphosphate in Dried Blood Spots in the Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort. Clin Infect Dis. 2026. PMID: 40972637. doi:10.1093/cid/ciaf509
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。